J Korean Med Sci.  2001 Feb;16(1):62-68. 10.3346/jkms.2001.16.1.62.

Expression of MAGE-1, -2, and -3 genes in gastric carcinomas and cancer cell lines derived from Korean patients

Abstract

We investigated the expression of MAGE-1, -2, and -3 genes in tissues of 51 gastric carcinomas from Korean patients and in 11 gastric cancer cell lines established in Korea using reverse transcriptase-polymerase chain reaction along with immunohistochemical analyses and DNA sequencing. Among the 51 gastric carcinomas, MAGE-1, -2, and -3 genes were expressed in 16 (31%), 22 (43%), and 17 (33%), respectively, and 31 (60%) expressed at least one of the three genes. In contrast, none of the three MAGE genes were expressed in normal sites of gastric tissue from each cancer patient. Out of 11 gastric cancer cell lines, MAGE-1, -2, and -3 genes were expressed in two (18%), five (46%), and four (36%), respectively. According to the clinicopathological analysis, the expression of any of the three MAGE genes was not significantly correlated with several clinicopathological factors except histologic types (p= 0.067). Immunohistochemical analyses identified positive staining with monoclonal antibodies 77B and 57B specifically against MAGE-1 and -3 proteins, respectively, in nuclei and cytoplasms of cells in mRNA-positive tumor tissue. These findings suggest the possibility as a target for tumor-specific immunotherapy for Korean patients.

Keyword

MAGE; Reverse Transcriptase-Polymerase Chain Reaction; Gene Expres; Immunohistochemistry

MeSH Terms

Antigens, Neoplasm/genetics*
Female
Human
Immunohistochemistry
Male
Middle Age
Neoplasm Proteins/genetics*
Neoplasm Proteins/analysis
RNA, Messenger/analysis
Reverse Transcriptase Polymerase Chain Reaction
Stomach Neoplasms/therapy
Stomach Neoplasms/pathology
Stomach Neoplasms/metabolism*
Tumor Cells, Cultured
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr